These words, put into the mouth of Banquo when he and Macbeth came across the three witches, are an evocation of the dismay caused by encountering a grossly hirsute woman. The reaction of the woman herself is often much stronger, with horror at her disfigurement and fear that the external signs may be but the superficial manifestation of an uncontemplatable transition towards masculinity. Thus disorders of androgen secretion and action in the female, said to occur in 3% of a Caucasian population 1, demand tact and sensitivity in their management, which, ifit is to be successful, requires a sound knowledge of pathogenesis.
It is the purpose of this paper to set such disorders in an historical and cultural context and to discuss the biochemical mechanisms that bring them about.
Historical background
The first description of hirsutism is said to be by Hippocrates", in whose writings is an account of two women on the Island of Cos who were notable for their growth of beard. Undoubtedly the ancients considered hirsutism worthy of record since there is a fresco from Pompei, which must have been painted before the eruption of Vesuvius in AD 97, depicting the Toilet of Hermaphrodite with a bearded woman assisting in the event, and there are many later representations such as that painted by Willem Keys (1520-1550)of 'The Woman With Two Beards' and the famous 'La mujer barbuda' (1631) by Ribera (1591-1652), commissioned by the Duke of Alcala. of Magdalena Ventura from the Abruzzi. This unfortunate, shown at the age of 52 bald and bearded but suckling her child, became hirsute when she was 37. The Duke was so fascinated by this that he had the sitter recorded for posterity -possibly the first example of deliberate clinical illustration. There is a reference by Henry Sampson in one of the earlier records of the Royal Society in 1697 of virilization in a girl, but it was not until 1865 that De Crecchio described congenital adrenal hyperplasia. and 1935 when Stein and Leventhal associated the polycystic ovaries previously identified by Chereau in 1884with menstrual disturbance and hirsutism.
The association between masculinization and endocrine pathology linking the adrenals and gonads was pointed out by Bullock and Sequeira in 1905 3 • This followed reports over the centuries associating virilization with specific organs, as the effects of castration were known since earliest times", The Chinese must have guessed that a substance was secreted from the testes since, according to Needham", they were already administering extracts of the glands in the 13th century for male hypogonadism and by the 15th century their chemists had discovered methods for the crude separation of steroids from urine, extracts of which were used therapeutically in the management of male 'sexual debility'. It was not until the early 19th century that there were significant advances in Europe in the subject when the observations of the Chinese were rediscovered, with first of all crude testis and then extract being found to produce sexual development in castrated animals. This formed the basis of the rejuvenating experiments of Brown-Sequard and led ultimately to a means of bioassay which was used by the chemists of the 1930s for the testing of the androgenic compounds relating to the parent chemical, androstane, that had been isolated and structured", Testosterone itself appeared on the scene in 1935 5 • From that time further androgens were found, and with the use of isotopic techniques the metabolic pathways were worked out, heralding the modern era.
Synthesis, metabolism and action The adrenal
The pathways involved in the biosynthesis of steroids by the adrenal gland are shown in Figure 1 . Inherited defects involving each enzymatic step occur clinically. The commonest of these is 21-hydroxylase deficiency transmitted as an autosomal recessive characteristic, with a population prevalence of 1: 5000 and a gene frequency of 1:39. When this occurs there is an accumulation of 17-hydroxyprogesterone (170HP), the blood level of which is used as a marker for the disease. Another intermediary that accumulates is androstenedione, which is metabolized to androgens thereby causing clinical virilism. One of the important metabolites of androstenedione is dehydroepiandrosterone (DHA). This is converted almost uniquely in the adrenal to DHA sulphate, so that determination of this product is useful as a marker of adrenal hyperactivity.
The ovary
Biosynthetic pathways operating within the ovary are shown in Figure 2 . Of particular relevance is the status of androstenedione as a precursor of both oestrogens and testosterone.
Metabolism of steroids secreted by ovary and adrenal
In normal women, 40% of the testosterone that is produced comes in approximately equal amounts from ovary and adrenal. The remaining 60% is produced in non-endocrine tissue such as liver, skin, adipose tissue and muscle from androstenedione secreted by the glands". Androstenedione is also converted to oestrone by extraglandular tissues 7 as well as being a precursor of dihydrotestosterone formed in androgen-sensitive cells". Dihydrotestosterone in the female may be secreted by the adrenal and ovary but is also produced within the skin via the action of 5-alpha-reductase on testosterone. The dihydrotestcsterone is then metabolized to S-alpha-androstenediol (Sa-diol)8, Testosterone, dihydrotestosterone and Sa-diol are all conjugated with glucuronic acid and excreted in the urine", The finding of elevated Sa-diol or its gluconuronide in blood or urine has been used to indicate increased androgenic activity due either to hypersecretion of precursors or enhanced conversion in target tissues, or both".
Clinical disorders
The effects of excessive androgen secretion are shown in Table 1 . The feature found most frequently is excessive growth of hair on the face and chin, round the nipples and on the abdomen and adductor surfaces of the thighs. This is often associated with excessive secretion of sebum and with acne. In addition to the signs of virilism listed in the table, excess androgen secretion may also 'defeminize', causing menstrual disturbance and, when present prepuberally, lack of mammary development and short stature due to premature epiphyseal fusion. 
Causes of hirsutism and virilism
The most common of the abnormalities involving androgens in the female are idiopathic hirsutism and the polycystic ovary syndrome. These two may be distinguished clinically on the menstrual history, although it has been reported recently? that the former may display the structural, but only rarely the hormonal, picture of polycystic ovaries. Congenital adrenal hyperplasia occurring in the adult can produce hirsutism and/or amenorrhea but is most usually associated with regular menses. Tumours of the ovary and adrenal are rare, with a luteoma of pregnancy being most unusual.
Further discussion will concentrate on the commoner conditions -polycystic ovary syndrome, congenital adrenal hyperplasia, idiopathic hirsutism -and their interrelationships.
Polycystic ovary syndrome (PCOS) Patients with this condition, first described by Stein and Leventhal in 1935, usually present with irregular periods, infertility or hirsutism. The irregular periods have aptly been described (Prunty, personal communication) as exhibiting 'menstrual chaos', in that the intervals between may vary from several days to many months with bleeding being scant, normal or excessive. The hirsutism may be absent or it may be gross, and sometimes there are other signs of virilism. Approximately half the patients are overweight. Diagnosis is nowadays usually made with ultrasound but laparoscopy is still employed on occasion. There is a characteristic pattern of hormonal abnormalities with an elevated ratio of luteinizing hormone (LH) to follicle-stimulating hormone (FSH) and a tendency to high concentrations of androstenedione, testosterone, DHAS and oestrone!", The use of frequent blood sampling has revealed that the elevated LH is due to increased frequency and amplitude of the secretory pulses (LH dysrhythmia) I I.
Mechanisms of ovulatory dysfunction
The observation that patients with polycystic ovaries have a tendency to elevated levels of androgens as well as an increase in androgen production rates has led to the speculation that this class of steroid may be responsible for the abnormal gonadotrophin dynamics. Indeed, experimental work in rata'? has demonstrated that administration of either testosterone or androstenedione or dehydroepiandrosterone can produce polycystic ovaries, and there are many clinical examples of the abnormality being found in association with congenital adrenal hyperplasia, Cushing's syndrome or androgenic tumours of the adrenal or ovary. Recently the structural features of polycystic ovarian disease have been recorded in female-to-male transsexuals who received testosterone for periods longer than a year ':'.
However, the view that it was the testosterone that was responsible for the menstrual disturbance has recently been questioned following the observation that this steroid administered for one month did not affect the cycle pattern of normally menstruating women!", Nor did testosterone or dihydrotestosterone infusions into women with polycystic ovaries have any effect on gonadotrophin dynamics IS. A third piece of evidence militating against a role of androgens in this context comes from the finding that, despite a background of endogenously secreted testosterone, it is possible to induce 'female' gonadotrophin responses in male-to-female transsexuals given oestrogens in the long-term!", Moreover, the majority of the female-to-male transsexuals given testosterone, while developing the structural features of polycystic ovaries, continued to menstruate regularly and some preserved the normal LH/FSH ratio!". Thus it is necessary to search for an alternative explanation for the ovulatory disturbance. Oestrone given to monkeys is a potent inhibitor of ovulation17, although it did not produce the elevation of LH as seen in PCOS. Oestrone levels have also been shown to correlate well with the abnormality of gonadotrophin release found in the polycystic ovary syndrome!", and a return of oestrone levels towards normal under the influence of dexamethasone is associated with a return of normal cycles. It therefore seems more likely that this product of androstenedione metabolism, rather than testosterone, could perturb the pituitary-gonadal interrelationship.
Sources ofabnormal steroids
It has been known for some time that there is a relative block in oestrogen formation by the follicle with the accumulation of androstenediona'". Ovarian venous sampling has added further support that the ovary is a source of the excessive androstenedione secreted in the condition 19. In addition, there is evidence for adrenal involvement. This gland is hyper-responsive in PCOS to the administration of ACTH 10 or when endogenous ACTH is increased following metyraponai". Among the steroids with elevated levels is DHAS, a substance coming from the adrenal and not the ovary. Further support for the view that there is an adrenal disturbance can be drawn from the demonstration that adrenal activity, as judged by increased uptake of monoiodomethylnorcholesterol, is enhanced in some patients with polycystic ovaries, and there are a number of patients who ovulate following the administration of corticosteroids-".
There are three possible explanations of these findings: (1) There is a primary ovarian abnormality with secondary effects on the adrenal. There are indeed data showing that oestrogens can inhibit the 3p-hydroxysteroid dehydrogenase" and there is a defect which has been identified in a group of patients with polycystic ovaries-". However, other experiments'" make it most unlikely that ovarian oestrogen significantly inhibits adrenal steroid pathways in peDS, since the concentrations required to do this are much more than those found in the clinical state. (2) The adrenal affects the ovary. This is a possibility in those patients in whom normal ovulation is restored by corticosteroids. The mechanism for this remains unclear, but is most likely to be as a consequence ofthe relevant steroid inhibitor -possibly oestrone-being reduced in concentration by therapy so that the hypothalamus or pituitary can function normally. However another, somewhat controversial, hypothesis has it that corticosteroids can act directly on the ovary24, (3) The defect lies outside the ovary and adrenal, and the abnormalities found in those glands are secondary. This remains a tenable hypothesis which still requires testing.
There is a small proportion of patients -around 10% -who have a hormonal pattern indistinguishable from that used by convention to diagnose congenital adrenal hyperplasia, namely an elevated 17-hydroxyprogesterone level with an exaggerated response to ACTH. Moreover, some patients with congenital adrenal hyperplasia have gonadotrophin responses identical to those found in PCOS2Sand the ovulatory disorder of this condition can sometimes be 
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Conclusion
A scheme setting out the hypothetical interrelationships between excessive hormonal activity of the adrenals or ovaries with possible clinical consequences is illustrated in Figure 3 . Disturbances of androgen metabolism can arise as a result of hypersecretion of androgens or androgenic precursors from either adrenal glands or ovaries or both. The precursor can be metabolized to active androgen in a variety of sites, including the skin itself where hirsutism is produced. The bulk of the evidence would suggest that androgens are not of themselves responsible for the LH dysrhythmia as found in PCas, but more likely the androgenic precursor, androstenedione, is converted to oestrone or to some other steroid which acts on the hypothalamic pituitary unit. The site of this conversion could be fat or liver or any other tissue wherein the necessary biochemical pathways are known to exist. Skin ? successfully treated when the underlying adrenal pathology is brought under control (Horrocks and London, in preparation).
Congenital adrenal hyperplasia
There is thus an a priori case for studying congenital adrenal hyperplasia (CAH) in relation to pcas. This has been done in a group of subjects complaining of hirsutism with or without menstrual disorders, the important presenting symptoms of the conditiorr'". The results showed that only 1.2% of patients suffered from CAH with deficiency of the 21hydroxylase. Indeed, the majority of patients presenting in adult life with CAH have regular menses and are genetically distinct from those suffering from the classical varieties of the condition where there is virilization with or without 'salt-wasting'P". Even though this condition may be of minor importance in relation to polycystic ovaries, the newer techniques of molecular genetics may be equally applicable.
_ The demonstration that there is linkage to certain HLA haplotypes in the variants ofCAH has indicated that the abnormal gene is situated on chromosome 6 and can be mapped in this region. Using techniques of DNA analysis with a complementary probe raised to part of the gene coding for the deficient enzyme, it has been possible to show certain polymorphisms when the genome has been digested with a variety of restriction endonucleases and hybridized with a specific probe'". Investigation has shown that the genetic abnormality is heterogeneous, there being no single common defect. This is in line with the heterogeneity of HLA haplotypes. This approach is also applicable to pcas, where a dominant mode of transmission has been postulated whether the disease has been diagnosed histologically-", using gynaecography't'' or ultrasound!'.
Idiopathic hirsutism
It has been estimated that approximately 3% of a Caucasian female population has hair on the upper lip and 6% have hair on the chin1. The level at which this comprises a clinical symptom depends on the attitude of the woman. Some may be distressed by the merest fuzz, whereas others seem to tolerate a fierce unshaven growth with equanimity. The degree of hirsutism correlates poorly with blood levels of androgens as usually measured. While there is a statistically significant elevation of testosterone and androstenedione in hirsute women, there are many examples where the hair is gross but the levels are normal. This has been attributed to increased activity in the skin of 5-alpha-reductase, the enzyme converting testosterone to dihydrotestosterone", on the basis of skin biopsy data and also through measurement of the 3a-diol or 3a-diol glucuronide in blood. This steroid, being a metabolite of dihydrotestosterone, is considered to reflect the formation of the potent androgen. Conversely, in some patients with late-onset adrenal hyperplasia who are not hirsute, 5-alpha-reductase activity in skin may be low, thereby explaining the clinical paradox of a smooth skin in the presence of a high serum testosterone 3 2 • This phenomenon has also been observed in patients with pcas, where there is a tendency for those who are hirsute to have high levels of 3adiol in contrast to the non-hirsute with normal concentrations of this substance-",
